---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-175113"
form_type: "8-K"
ticker: "BOLT"
cik: "0001641281"
company_name: "Bolt Biotherapeutics, Inc."
filed_at: "2024-07-03T23:59:59+00:00"
generated_at: "2026-05-31T23:29:41.060513+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bolt Biotherapeutics receives Nasdaq bid price deficiency notice; 180 days to comply

## Summary
- Avg closing price of common stock fell below $1.00 over prior 30 trading days as of July 1, 2024.
- 180-day grace period until Dec 30, 2024 to regain compliance by closing at $1.00+ for 10 consecutive business days.
- If not compliant, may qualify for an additional 180-day extension if other listing standards met.
- Company intends to monitor bid price and evaluate options including potential reverse stock split.
- Notice has no immediate effect on listing; stock continues trading on Nasdaq Global Select Market.

## SEC filing metadata
- accession: 0001193125-24-175113
- form_type: 8-K
- ticker: BOLT
- cik: 0001641281
- company_name: Bolt Biotherapeutics, Inc.
- filed_at: 2024-07-03T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641281/000119312524175113/0001193125-24-175113-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641281/000119312524175113/d796654d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-175113
- JSON: https://secwatch.observer/filing/0001193125-24-175113.json
- Plain text: https://secwatch.observer/filing/0001193125-24-175113.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.